Recreational physical activity (RPA) is associated with a reduced risk of developing breast cancer, but there is limited research on whether prediagnostic RPA influences survival after breast cancer diagnosis or not. We evaluated the association between prediagnostic RPA and risk of death in 1508 women with a first breast cancer diagnosis during 1996 and 1997 in the population-based Long Island Breast Cancer Study Project. A 5-year mortality, through the end of 2002, was assessed using the National Death Index (N = 196). An in-person interview was completed shortly after diagnosis to obtain information on lifetime RPA, which was expressed as metabolic equivalent task hours per week (MET-h/week). A lower risk of all-cause death was observed for women who engaged in an average of 9 or more MET-h/week of RPA from menarche to diagnosis compared with women who did not exercise [age-adjusted and BMI adjusted hazard ratio (HR) = 0.57; 95% confidence interval (CI) = 0.39-0.83], an association that was similar when evaluated according to menopausal status. Compared with women who did not engage in moderate RPA, those who engaged in any moderate intensity lifetime RPA ( > 0 MET-h/week) were found to have lower all-cause mortality (HR = 0.62; 95% CI = 0.46-0.84) and breast cancer-specific mortality (HR = 0.64; 95% CI = 0.43-0.93). Among postmenopausal women, RPA that took place after menopause resulted in a decrease in overall mortality, whereas no association was observed for RPA which took place prior to menopause (for > 0 MET-h/week of RPA vs. no RPA, the HR = 0.61; 95% CI = 0.39-0.94 and HR = 1.00; 95% CI = 0.65-1.54, respectively). This study provides support that RPA prior to breast cancer diagnosis improves survival.
Introduction
There is convincing evidence for an inverse relationship between physical activity and breast cancer with many studies reporting a 20-30% decreased risk of developing breast cancer for those who are physically active, and most reporting a dose-response relationship (Monninkhof et al., 2007; Friedenreich, 2010) . The inverse relationship of breast cancer with physical activity has been consistently observed in both cohort and case-control studies and across many subgroups including both premenopausal and postmenopausal women, and different intensities of physical activity, and appears to be independent of obesity and hormone receptor status (Friedenreich, 2004; Friedenreich and Cust, 2008) . Further, a recent review suggests that recreational physical activity (RPA), rather than occupational, household, and transportation, is associated with the greatest decreases in risks observed for physical activity on breast cancer occurrence (Friedenreich and Cust, 2008) . Similar mechanisms for breast cancer risk and survival are thought to be involved, including direct reduction in exposure to sex steroid hormones, reduced insulin and insulin-like growth factors, modulation of inflammation, and indirectly through reduced adiposity (McTiernan, 2006) . Therefore, increasing physical activity is a promising preventive measure for reducing risk of death after a breast cancer diagnosis.
Although there is ample evidence supporting a reduction in breast cancer risk for higher levels of physical activity, fewer studies have examined whether exercise influences mortality among breast cancer survivors or not. Both casecontrol and cohort studies have investigated this association, most finding an inverse association between physical activity and survival (Rohan et al., 1995; Enger and Bernstein, 2004; Abrahamson et al., 2006; Pierce et al., 2007; Irwin et al., 2008; Friedenreich et al., 2009) . However, only a few studies have investigated intensity of RPA on breast cancer survival (Rohan et al., 1995; Friedenreich et al., 2009; Bertram et al., 2011) , and to our knowledge, no studies have evaluated the effect of the timing of physical activity during the lifetime on survival after breast cancer diagnosis.
The purpose of this study was to examine whether the amount, intensity, duration, and timing of prediagnostic physical activity influences risk of death after a breast cancer diagnosis in the Long Island Breast Cancer Study Project (LIBCSP), population-based cohort of women with breast cancer.
Patients and methods

Study population
This study draws on data that were collected from participants as part of the Long Island Breast Cancer Study Project, a population-based study of English-speaking residents of Nassau and Suffolk counties of Long Island, New York (Gammon et al., 2002) . LIBCSP participants were women newly diagnosed with a first primary in situ or invasive breast cancer between 1 August 1996 and 31 July 1997. Women were identified using a rapid reporting system established specifically for the LIBCSP and were confirmed by physician's and medical records. The attending physician was contacted to confirm study eligibility and to seek permission to contact the patient. Institutional review board approval of the study protocol was obtained from each collaborating institution and participating hospital, and a written informed consent was obtained from each participant before the interview. A total of 1508 women with breast cancer, of whom 1273 had invasive breast cancer, participated in the LIBCSP baseline case-control study interview, which was administered shortly after diagnosis. As part of the LIBCSP follow-up of the case women, vital status through the end of 2002 was determined through the National Death Index (NDI).
Data collection Baseline data
The lifetime physical activity and most of the covariate data used in this analysis were collected as part of the LIBCSP baseline interview. The main questionnaire was administered in-home by a trained interviewer and took approximately 2 h to complete. Information obtained from the main questionnaire includes reproductive and menstrual history, exogenous hormone use, family history of cancer, body size, physical activity, smoking history, alcohol intake, and demographic characteristics. Nearly two-thirds of baseline case interviews occurred before initiation of chemotherapy (Gammon et al., 2002) . Descriptive characteristics for the entire LIBCSP study have been previously published (Gammon et al., 2002) .
As a part of the baseline interview, participants reported participation in RPA using an instrument which was a modification of that developed by Bernstein and colleagues (Bernstein et al., 1994 Carpenter et al., 1999 .
Participants were asked about all RPAs in which they had engaged for at least 1 h per week for at least 3 months or more in any year over their entire lifetime, but prior to the breast cancer diagnosis. Activity information recorded was the name of the activity, the ages at which the activity was started and stopped, the total years of participation in the activity, the number of months per year, and the number of hours per week the activity was usually performed.
Treatment and tumor characteristics data
Information on treatment undergone for the first primary breast cancer is based on response at baseline and during follow-up. Nearly two-thirds of participants with breast cancer completed their baseline interview prior to the initiation of chemotherapy, therefore additional treatment information was obtained by trained interviewer through telephone contact from 1098 case participants or their proxies in 2002-2004 and by reabstracting medical records. There were 410 cases without follow-up interview data due to nonresponse, refusal, untraceability, or death without an identifiable proxy.
Data on estrogen receptor and progesterone receptor status were gathered from medical records of 1402 women who signed a medical release form. Treatment and tumor characteristics data were abstracted for 598 women. A high concordance was found between information abstracted from records and self-reported radiation therapy (k = 0.97), chemotherapy (k = 0.96), and hormone therapy (k = 0.92). Thus, for this study, the analysis is based on self-reported treatment at the baseline and at follow-up interviews.
Study outcome
For the LIBCSP follow-up study, the NDI was used to ascertain all-cause and breast cancer-specific mortality among study participants. As most women who die from breast cancer will do so within 5 years of diagnosis (Janssen-Heijnen et al., 2007) , we are reporting survival after 5 years of follow-up. Participants were followed from diagnosis until 31 December 2002. Among the 1508 women diagnosed with breast cancer, 198 (13.1%) deaths occurred. On the basis of the International Classification of Diseases codes 174.9 and C-50.9 listed as a primary or secondary code on the death certificate, 128 (64.6%) deaths were due to breast cancer. Cases without a death record in the NDI database were determined to be alive as of 31 December 2002.
Variable definitions Recreational physical activity
Among participants classified as ever having participated in RPA, a duration-frequency measure was calculated using the reported number of hours per week of participation summed across all activities for each year of a woman's life. This combined duration and frequency measure was calculated as hours per week of activity and examined among all women. This variable was then further divided among subcategories of specific time periods during the lifecourse, including RPA over the lifetime (expressed as hours per week of RPA from menarche to diagnosis), premenopausal RPA (for postmenopausal women only, RPA from menarche up to Physical activity and breast cancer survival Cleveland et al. 47 menopause), RPA from onset of menopause to diagnosis, and recent RPA (within 10 years prior to diagnosis). There were 1504 case women who had a valid response for physical activity.
Metabolic equivalent task (MET) scores were assigned to each reported activity using a published database as a guide (Ainsworth et al., 1993) . One MET is defined as the energy expended when sitting quietly, which is equal to 3.5 ml of oxygen per kilogram of body weight per minute, or 1 kcal/kg of body weight per hour (Ainsworth et al., 1993) . This MET score was then multiplied by the number of hours per week the individual reported in engaging in the activity to derive MET-hours per week (MET-h/week) that were averaged for annual activity levels for the specific lifecourse time periods described above. Use of this measure in analyses allowed for simultaneous examination of activity duration and frequency in relation to risk of breast cancer. Total RPA was further classified according to intensity, where low intensity activities were defined as those expending < 3 METs, moderate intensity activities expending Z 3-< 6 METs, and high intensity activities expending Z 6 METs (Pate et al., 1995) .
Covariates
Self-reported data on potential covariates were gathered through interviewer-administered questionnaires at baseline (in person) and at follow-up (by telephone), and included prediagnostic factors related to demography (race, income, education, marital status), reproduction (parity, age at first live birth, breast feeding), and menstruation (age at menarche, age at menopause). Prediagnostic exogenous hormone use was also considered (hormonal birth control, hormone replacement) along with prediagnostic medical history (benign breast disease, family history of breast cancer), lifestyle factors [lifetime average alcohol consumption, dietary fat (grams/ day), total caloric intake (kilocalories/day)], cigarette smoking, history of comorbidities reported at the baseline interview (high cholesterol, history of blood clots, diabetes, hypertension, previous myocardial infarction and stroke), the tumor characteristics (tumor stage, tumor size, and nodal status), and treatment undergone (chemotherapy, radiation, tamoxifen) for the original breast cancer diagnosis.
Menopausal status was derived using information provided on the baseline questionnaire (Gammon et al., 2002) . Postmenopausal status was defined as having a last menstrual period more than 6 months before the date of diagnosis or if both ovaries were removed before the date of diagnosis. Women with unknown menopausal status were categorized as postmenopausal based on the 90th percentile for age at menopause in the control population from the baseline study, and calculated according to smoking status (Z 54.8 years for smokers and Z 55.4 years for nonsmokers).
Statistical methods
Lifetime RPA was defined as RPA from menarche to diagnosis. RPA analyses were also carried out for the life periods from menarche to menopause, menopause to diagnosis, and recent RPA (within 10 years prior to diagnosis). To reduce the possibility that RPA by life period associations we observed were due to the differences in sample size, the analyses for timing of RPA was restricted to women who had a reported RPA measure at each time point. Physical activity variables were classified as MET-h/week in categories defined as 0, > 0-8.9, and 9 or more MET-h/week. These cutpoints were selected based on Centers for Disease Control and Prevention and the American College of Sports Medicine recommendations for physical activity (Pate et al., 1995) as well as for consistency with other investigations by Holmes et al. 2005 (< 3, 3-8.9, 9-14.9, 15-23.9 , and 24 or more MET-h/week) and Irwin et al. (2008) (0, > 0-8.9, and 9 or more MET-h/week).
Kaplan-Meier methods (Allison, 1995) were used to generate survival curves by RPA category (data not shown). Cox proportional hazards regression (Allison, 1995) was used to estimate hazard ratios (HR) and 95% confidence intervals (95% CI) for the risk of all-cause and breast cancer-specific mortality. Participants with in-situ disease were excluded when calculating breast cancerspecific mortality estimates. Proportional hazards assumptions were verified with Schoenfield residuals. No violation of this assumption was found. The results for overall and 5-year survival were similar; therefore, only overall survival is reported. Tests of trend were conducted using the continuous values for RPA.
Effect measure modification on the multiplicative scale between categorical RPA variables and other covariates was evaluated using the log likelihood ratio test to compare proportional hazards regression models with and without the crossproduct terms (Allison, 1995) . To assess for potential heterogeneity, we evaluated effects stratified by variables, which included exogenous hormone use (never used hormones, ever used hormones), body mass index (BMI) (median BMI = weight in meters/height in meters squared), menopausal status (premenopausal, postmenopausal), and family history of breast cancer in a first-degree relative (no family history, family history). Associations were also evaluated by stratification on the tumor characteristics estrogen receptor status (negative, positive), progesterone receptor status (negative, positive), tumor stage (in situ, invasive), nodal status (nodenegative, node-positive), and tumor size (< 2 cm, Z 2 cm).
For assessment of confounding, variables were included in multivariate models if they were related to either the exposure (RPA) or the outcome (death). Using backward elimination, potential confounders were removed from models beginning with those with the highest P value. Variables remained in the final models if their inclusion changed the estimate of effect by more than 10% (Hosmer and Lemeshow, 1989) . Adjustment for most factors did not substantially alter the estimates of effect therefore all models include only age at diagnosis and BMI in the year prior to the diagnosis. Models including both premenopausal and postmenopausal women were also adjusted for menopausal status.
To further explore possible confounding by tumor characteristics and treatment, we conducted separate analyses restricted to women for whom we have complete tumor characteristics and tumor treatment data. There were no differences in effects or evidence of confounding by these variables for the relationship between RPA and mortality. All analyses were carried out using SAS/STAT software version 9.1 (SAS Institute, Cary, North Carolina, USA).
Results
There were 196 deaths identified, of which 128 were due to breast cancer. Mean follow-up was 66.7 months (range: 2.7-88.6 months). Distributions of selected characteristics by total MET-h/week of RPA from menarche up to diagnosis among women with breast cancer are shown in Table 1 . Women who engaged in RPA during this time tended to be younger at diagnosis, more likely to have completed high school, had a lower BMI, and were more likely to have taken exogenous hormones than those who were inactive. There was little difference in estrogen receptor or progesterone receptor status in physically active women compared with inactive women.
Results for analyses that examined the association between overall lifetime physical activity and intensity of lifetime physical activity are shown in Table 2 . Each category of lifetime RPA above 0 MET-h/week showed a modest decreased risk of both all-cause and breast cancer-specific mortality. Compared with women who never participated in RPA, those with high levels of RPA (Z 9 MET-h/week) had improved survival from all causes for total lifetime RPA (HR = 0.57; 95% CI = 0.39-0.83). The results for no RPA versus any RPA, regardless of MET-h/week, were similar to those seen for the highest levels of activity ( Z 9 MET-h/week) for both all-cause and breast cancer-specific mortality, where women who engaged in any lifetime RPA had a 42% decrease in risk of death due to all causes (HR = 0.58, 95% CI = 0.43-0.91) and a 37% reduced risk of death due to breast cancer (HR = 0.63; 95% CI = 0.43-0.91). No significant trends were observed for reduced mortality with increasing MET-h/week of RPA (data not shown).
Moderate intensity lifetime RPA also resulted in decreased mortality, where those who reported ever participating in regular moderate RPA had lower risk of death attributed to breast cancer RPA (HR = 0.64; 95% CI = (0.43-0.93) and all-causes (HR = 0.62; 95% CI = 0.46-0.84) compared with those who never engaged in moderate RPA. There was no decreased association with mortality observed for those who engaged in vigorous intensity physical activity.
Among premenopausal women, 5-year survival for those who engaged in any lifetime RPA was 93%, whereas 5year survival for inactive women was 85% (Fig. 1a) . Similarly, among postmenopausal breast cancer participants the 5-year survival for any cause was 90% for active women and 83% for inactive women (Fig. 1b ). Associations were similar, although slightly attenuated, for breast cancer-specific mortality. We further evaluated the association of lifetime RPA stratified by menopausal status and found no evidence of statistically significant interaction (P for interaction = 0.48). Lifetime RPA among premenopausal women was associated with modest decreases in all-cause and breast cancer-specific mortality regardless of MET-h/week of activity (any RPA vs. no RPA: HR = 0.53; 95% CI = 0.28-0.97; HR = 0.54; 95% CI = 0.27-1.05, respectively), although there were no apparent trends for reduced risk of death with increasing RPA (Table 3) . Similar, although attenuated, reduced associations that approached statistical significance were seen for low levels of RPA (up to 8.9 MET-h/week) and for high levels (greater than 9.0 MET-h/week) among postmenopausal women. Physical activity and breast cancer survival Cleveland et al. 49 When considering the timing of physical activity among postmenopausal women, we observed that engaging in exercise after menopause was associated with a reduced risk of death due to all causes, whereas there was no effect for physical activity which took place before menopause (Table 4 ). Compared with inactive women, those women who engaged in 9 MET-h/week or more of RPA after menopause had a 67% lower risk of death (HR = 0.33; 95% CI = 0.17-0.63, P for trend = 0.002). Results for breast cancer-specific mortality were similar, but not as strong as those seen for deaths from all causes. Postmenopausal women who engaged in physical activity in the 10 years prior to diagnosis showed similar results for all-cause mortality as those seen for RPA after menopause (Z 9 MET-h/week vs. no RPA: HR = 0.33; 95% CI = 0.18-0.61).
Analyses of overall and breast cancer mortality stratified by BMI is shown in Table 5 . We observed no decreasing trend in overall or breast cancer-specific mortality for those with increasing levels of RPA in either normal weight or overweight/obese women. Similar associations for breast cancer-specific mortality were seen for women who were normal weight and those who were overweight/ obese. However, when examining the effects of any lifetime RPA versus no RPA on all-cause mortality, women with a BMI < 25 had a 56% decrease in risk of death whereas the protective effect of RPA on all-cause death for women with a BMI Z 25 was not as strong (HR = 0.44, 95% CI = 0.27-0.70; HR = 0.66; 95% CI = 0.46-0.96, respectively; P for interaction = 0.08). Lifetime recreational physical activity defined as being from menarche to reference date; reference date is date of diagnosis for cases. c Moderate intensity recreational physical activity includes activities that expend Z 3.0 or < 6.0 metabolic equivalent task. d Additionally adjusted for vigorous physical activity (activities that expend Z 6.0 metabolic equivalent task). e Vigorous intensity recreational physical activity includes activities that expend Z 6.0 metabolic equivalent task. f Additionally adjusted for moderate physical activity (activities that expend Z 3.0 or < 6.0 metabolic equivalent task). Examination of effect modification of the association of RPA with breast cancer survival by other factors such as hormone receptor status, tumor stage, and exogenous hormone use did not reveal any differential associations, and is not reported here.
Discussion
We evaluated the association of breast cancer survival with prediagnostic RPA based on frequency, intensity, duration, and timing. We found that women who reported ever being physically active prior to diagnosis had a reduced risk of mortality from any cause. These findings were observed among women diagnosed with both premenopausal and postmenopausal breast cancer, and regardless of their hormone receptor status. The risk reduction in mortality was stronger, near 50% reduction, among those postmenopausal women who were reported to engage in any prediagnostic RPA versus no RPA during their postmenopausal years, rather than their premenopausal years. There was also evidence that moderate intensity RPA, but not vigorous, improved both all-cause and breast cancer-specific survival. In addition, postmenopausal women had greater survival with increased RPA during the postmenopausal years. We did not, however, observe any effect measure modification by BMI, although the observed reduced mortality was somewhat stronger in women with a normal BMI (< 25). Physical activity and breast cancer survival Cleveland et al. 51 Our results are consistent with the population studies that have been previously published on this issue to date (Holmes et al., 2005; Abrahamson et al. 2006; Friedenreich et al., 2009) , even though different exposure assessment methods and study populations were utilized. For example, Abrahamson et al. (2006) also focused on selfreported, prediagnostic levels of moderate and vigorous RPA only among younger women, which were assessed at three different time periods (age: 12-13 years and 20 years, and in the year prior to the breast cancer diagnosis), rather than the lifetime assessment we included here.
That study found that the 22% risk reduction in mortality among young women was limited to the most recent prediagnostic RPA, which is more attenuated, but still fairly consistent with our findings reported here of a 30-50% reduction associated with activity in the past 10 years among postmenopausal women. Thus, both of these studies suggest a recency effect, that more activity undertaken in the years leading up to a breast cancer diagnosis may exert stronger beneficial effects on mortality risk than activity undertaken in the distant past. Alternatively, our results may indicate that recent prediagnostic RPA levels are strongly correlated with postdiagnostic RPA levels, which have been reported to also be associated with a modest reduction in the risk of death in two recent studies (Holmes et al., 2005; Holick et al., 2008) . Unfortunately, neither study reported findings on whether women who were consistently active both before and after a breast cancer diagnosis had the best survival advantage, nor whether women who reported being active after their breast cancer diagnosis were also active prior to their diagnosis. Another recent study examined change in physical activity from 1 year before to 3 years after diagnosis and found that those who decreased their physical activity by more than 3 MET-h/ week had an increased risk of death compared with those who were inactive both before and after diagnosis (Irwin et al., 2008) . However, it was not reported whether the women who had decreased their physical activity were in the lowest or highest physical activity group before diagnosis. Thus, whether the beneficial effects on mortality associated with prediagnostic and postdiagnostic levels of RPA actually reflect the same optimal time period or two different time periods that are each associated with its own beneficial effects on survival remains unknown at this time. Similarly, it is also unclear whether breast cancer survival is affected by the change in the amount of RPA from before to after diagnosis. There are some studies that have shown that postdiagnosis physical activity levels briefly decline, but return to similar levels within 3 years (Irwin et al., 2004) . Future studies should focus on elucidating the effects of timing of the physical activity, and whether the RPA should be initiated prior to the diagnosis of breast cancer to fully benefit from its positive effects on survival, or whether activity initiated after diagnosis is sufficient.
Although moderate activity levels were associated with a better survival advantage, associations for intense activity levels were weaker, an observation which is consistent with findings from animal studies (Shephard, 1996) . Our results for intensity of physical activity on survival after breast cancer are also similar to those found in two recent studies of prediagnostic RPA and breast cancer survival and another study investigating postdiagnosis physical activity, both reporting a lower risk of death for moderate activity and finding no association of vigorous intensity activity (Holick et al., 2008; Friedenreich et al., 2009; Sternfeld et al., 2009) . Similarly, several studies have found no decreased risk for breast cancer development with vigorous intensity of activities (Friedenreich et al., 2001; Margolis et al., 2005; Schnohr et al., 2005) . However, a recent study found greater survival from breast cancer, but not for all-cause, with vigorous activity ; and the Nurse's Health Study found that vigorous exercise after diagnosis also lowered risk of breast cancer death (Holmes et al., 2005) . We are unsure why vigorous intensity exercise did not improve survival in our study, however one possible explanation could be the low reporting of vigorous activities and lack of adequate variation of vigorous intensity activities in our population, where only one-third of the population had ever engaged in vigorous RPA.
There are several limitations to this study that warrant mention. As with all studies that rely on self-reported measures of physical activity, measurement error, and the accompanying attenuation in the effect estimate, is of concern (Shephard, 2003) . We attempted to minimize the effects of poor measurement by relying on the instrument developed by Bernstein et al. (1994 ) (Carpenter et al., 1999 , which considers activity type, duration, intensity, and frequency. To optimize Bernstein's method, we linked it to a life event calendar, a memory aid that is used to enhance recall of dates and activities. Given the limited number of outcome events, our observed risk reductions in mortality associated with RPA were strongest for all-cause, rather than breast cancer-specific, mortality. Although the HRs for breast cancer-specific mortality were consistently below the null, we could not rule out an effect size of 1, as was often observed for all-cause mortality. In addition, in this study we had limited power to detect effect modification, therefore our stratified analyses should be interpreted as exploratory, and should be confirmed by other studies.
Many investigators have speculated on the biologic mechanism linking physical activity to the risk of developing breast cancer, including the insulin resistance pathway, inflammation, and DNA repair (Friedenreich and Orenstein, 2002; Rundle et al., 2005; McTiernan, 2006; Hursting et al., 2007) . Perhaps, the beneficial effects of RPA may simply be accomplished through avoiding weight gain (Huang et al., 1997; Cleveland et al., 2007) . However, the precise mechanism remains elusive. For example, as we discussed above, controlling for prediagnostic body size did not substantially affect our effect estimates reported here. Similarly, previous studies have been unable to detect a strong and consistent association between RPA and levels of insulin-like growth factor-1 (Manetta et al., 2003; Hambrecht et al., 2005; Irwin et al., 2009) . Thus, whether these same potential mechanisms also underlie the RPA-breast cancer survival link is currently unknown. A recent review, however, attempted to elucidate these mechanisms and summarized the literature for proposed common biomarkers in relation to breast cancer risk and physical activity separately. This study reported that after evaluating BMI, estrogens, androgens, sex hormone binding globulin, leptin, adiponectin, markers of insulin resistance, tumor necrosis factor-A, interleukin-6, and C-reactive protein, only BMI and estrogen showed convincing evidence of an association with both breast cancer and physical activity (Neilson et al., 2009) . Future studies should focus on understanding the underlying biologic mechanisms, which would strengthen our evidence linking RPA to risk reductions in breast cancer incidence and mortality.
In conclusion, this population-based study of women with breast cancer provides some evidence for a modest beneficial effect of lifetime RPA on survival outcomes. The beneficial effect was even stronger for postmenopausal women who engaged in RPA during their postmenopausal years, rather than their premenopausal years, suggesting that there is a particular period during adulthood when RPA could be most beneficial for prognosis. Whether this survival advantage is due to activity undertaken prior to diagnosis, as we and Abrahamson et al. (2006) report, or whether it reflects activity undertaken after diagnosis, as reported by other investigators (Holmes et al., 2005; Holick et al., 2008) , or both, currently remains unclear. Nevertheless, RPA appears to be a promising strategy to reduce the risk of mortality among breast cancer survivors.
